New Hepatitis C Drug Incivek Gets FDA Approval
The FDA has approved Incivek as an add-on to current interferon/ribavirn therapy for hepatitis C infection. Like Victrelis, also approved this month, Incivek greatly boosts the cure rate for hepatitis C.
Click here to read the full story.
No profanity or inappropriate comments will be allowed.
Offensive posters will be blocked from future postings.